Quote | Biofrontera Inc. (NASDAQ:BFRI)
Last: | $0.84 |
---|---|
Change Percent: | 2.58% |
Open: | $0.869 |
Close: | $0.84 |
High: | $0.891899 |
Low: | $0.84 |
Volume: | 28,484 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Biofrontera Inc. (NASDAQ:BFRI)
The RhodoLED XL is approved by the FDA in combination with Ameluz ® (aminolevulinic acid hydrochloride) topical gel, 10% for photodynamic therapy (PDT) of actinic keratoses of mild-to-moderate severity on the face and scalp Biofrontera launched the commercial distribution of the Rhod...
2024-05-16 14:44:07 ET Biofrontera Inc. (BFRI) Q1 2024 Earnings Conference Call May 16, 2024, 10:00 AM ET Company Participants Andrew Barwicki - Barwicki Investor Relations Hermann Luebbert - Chief Executive Officer, Chairman and Founder Fred Leffler - Chief Fina...
Message Board Posts | Biofrontera Inc. (NASDAQ:BFRI)
Subject | By | Source | When |
---|---|---|---|
$BFRI MomentumIts gaining | Atom Smasher | investorshub | 07/02/2023 10:25:40 PM |
and the shorts continue | da_stock_analyst | investorshub | 07/01/2023 4:33:06 PM |
just the news we needed | rocco_p_coletrain | investorshub | 07/01/2023 7:19:40 AM |
$BFRI Lets go go go go... Up up and away we go. | StockLogistics | investorshub | 07/01/2023 12:49:52 AM |
good read | StockLogistics | investorshub | 06/30/2023 3:32:57 AM |
News, Short Squeeze, Breakout and More Instantly...
The RhodoLED XL is approved by the FDA in combination with Ameluz ® (aminolevulinic acid hydrochloride) topical gel, 10% for photodynamic therapy (PDT) of actinic keratoses of mild-to-moderate severity on the face and scalp Biofrontera launched the commercial distribution of the Rhod...
Conference call begins at 10:00 a.m. Eastern time on Thursday, May 16, 2024 WOBURN, MA / ACCESSWIRE / May 15, 2024 / Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, today reported financial results f...
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...